These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32530104)

  • 1. High-speed visualization of ingested, ejected, adherent, and disintegrated thrombus in contemporary ventricular assist devices.
    Rowlands GW; Antaki JF
    Artif Organs; 2020 Nov; 44(11):E459-E469. PubMed ID: 32530104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational characterization of flow and blood damage potential of the new maglev CH-VAD pump versus the HVAD and HeartMate II pumps.
    Zhang J; Chen Z; Griffith BP; Wu ZJ
    Int J Artif Organs; 2020 Oct; 43(10):653-662. PubMed ID: 32043405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of the Frequency, Severity, and Propagation of Thrombi in the HeartMate II Left Ventricular Assist Device.
    Rowlands GW; Pagani FD; Antaki JF
    ASAIO J; 2020; 66(9):992-999. PubMed ID: 32243265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
    Florisson DS; Conte SM; De Bono JA; Newcomb AE
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Ventricular Assist Device Flow Pattern Analysis Using a Novel Model Incorporating Left Ventricular Pulsatility.
    Grinstein J; Torii R; Bourantas CV; Garcia-Garcia HM
    ASAIO J; 2021 Jul; 67(7):724-732. PubMed ID: 33528162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic features of thrombosis events with a centrifugal left ventricular assist device.
    Jessen SL; Kaulfus CN; Chorpenning K; Ginn-Hedman AM; Tamez D; Weeks BR
    J Heart Lung Transplant; 2021 Jan; 40(1):56-64. PubMed ID: 33339557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombus on the inflow cannula of the HeartWare HVAD: an update.
    Glass CH; Christakis A; Fishbein GA; Watkins JC; Strickland KC; Mitchell RN; Padera RF
    Cardiovasc Pathol; 2019; 38():14-20. PubMed ID: 30399526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices.
    Numan L; Zimpfer D; Zadok OIB; Aarts E; Morshuis M; Guenther SPW; Riebandt J; Wiedemann D; Ramjankhan FZ; Oppelaar AM; Ben-Gal T; Ben-Avraham B; Asselbergs FW; Schramm R; Van Laake LW
    ESC Heart Fail; 2023 Jun; 10(3):1656-1665. PubMed ID: 36798028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
    Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
    J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Aspirin Nonresponders Identification by Routine Use of Aggregometry Test in Patients With Left Ventricle Assist Devices Reduces the Risk of Pump Thrombosis.
    Montalto A; Comisso M; Cammardella A; Nicolò F; Gherli R; Palermo A; Pulcinelli F; Musumeci F
    Transplant Proc; 2019 Nov; 51(9):2986-2990. PubMed ID: 31711580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
    Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
    Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Mathematical Numerical Model to Evaluate the Risk of Thrombosis in Three Clinical Ventricular Assist Devices.
    Li Y; Wang H; Xi Y; Sun A; Deng X; Chen Z; Fan Y
    Bioengineering (Basel); 2022 May; 9(6):. PubMed ID: 35735478
    [No Abstract]   [Full Text] [Related]  

  • 14. VADoscopy: a novel intraoperative technique to evaluate HeartMate II left ventricular assist device inflow obstruction and thrombosis.
    Cheng A; Swartz MF; Massey HT
    ASAIO J; 2013; 59(6):671-4. PubMed ID: 24088904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-indicator analysis of mechanical blood damage with five clinical ventricular assist devices.
    Li Y; Wang H; Xi Y; Sun A; Deng X; Chen Z; Fan Y
    Comput Biol Med; 2022 Dec; 151(Pt A):106271. PubMed ID: 36347061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Neurologic Event Rates Among HeartMate II, HeartMate 3, and HVAD.
    Li S; Beckman JA; Cheng R; Ibeh C; Creutzfeldt CJ; Bjelkengren J; Herrington J; Stempien-Otero A; Lin S; Levy WC; Fishbein D; Koomalsingh KJ; Zimpfer D; Slaughter MS; Aliseda A; Tirschwell D; Mahr C
    ASAIO J; 2020 Jun; 66(6):620-624. PubMed ID: 31609791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboresistance comparison of the HeartMate II ventricular assist device with the device thrombogenicity emulation- optimized HeartAssist 5 VAD.
    Chiu WC; Girdhar G; Xenos M; Alemu Y; Soares JS; Einav S; Slepian M; Bluestein D
    J Biomech Eng; 2014 Feb; 136(2):021014. PubMed ID: 24337144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing short-term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®.
    Schramm R; Zittermann A; Morshuis M; Schoenbrodt M; von Roessing E; von Dossow V; Koster A; Fox H; Hakim-Meibodi K; Gummert JF
    ESC Heart Fail; 2020 Jun; 7(3):908-914. PubMed ID: 32190985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat Generation in Axial and Centrifugal Flow Left Ventricular Assist Devices.
    Yost G; Joseph CR; Royston T; Tatooles A; Bhat G
    ASAIO J; 2016; 62(6):684-689. PubMed ID: 27660906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.